510(k) Report

510(k) · Cleared

Cleared

Precision G Blood Glucose Testing System

K963676510(k) TraditionalCleared Feb 20, 1997160-day reviewClass II21 CFR 862.1345

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Medisense, Inc. · CGA Glucose Oxidase, Glucose

Cleared on Feb 20, 1997 as substantially equivalent to K944195 (Medisense, Inc., 1995) and 3 other predicates after a 160-day review. Its family tree reaches back 2 generations to 1995. 3 of the 66 devices in its family, counting itself, have a Class I recall. 60 later devices descend from it.

Decided
Feb 20, 1997
Review
160 days
Class
Class II
Product code
CGA
Recalls
None
Predicates
4

Its longest line of descent runs back 2 generations to K945887 (1995). 5 ancestors in all, the oldest K896951 (1990). 60 later devices descend from it, 3 citing it directly. 3 of the 66 devices in this family, counting this one, have a Class I recall.

Other ancestors, by year clearedDescendants, by year cleared 1995: 2 other ancestors1990: 1 other ancestor1999: 1 descendant cleared1998: 1 descendant cleared1997: 1 descendant cleared2002: 3 descendants cleared2005: 4 descendants cleared2008: 7 descendants cleared2006: 6 descendants cleared2004: 2 descendants cleared2010: 5 descendants cleared, 3 with a Class I recall32007: 5 descendants cleared2009: 4 descendants cleared2013: 6 descendants cleared2018: 3 descendants cleared2016: 3 descendants cleared2022: 2 descendants cleared2021: 1 descendant cleared2012: 2 descendants cleared2020: 1 descendant cleared2011: 1 descendant cleared2015: 2 descendants clearedK945887 · Precision Q I D Blood Glucose Test Strips · Medisense, Inc. · 1995K962295 · Precision Qid Blood Glucose Test Strip · Medisense, Inc. · 19961990200020102020
Other ancestors, by generationDescendants, by generation 1 generation back: 2 other ancestors2 generations back: 1 other ancestor 1 generation forward: 3 descendants2 generations forward: 9 descendants3 generations forward: 10 descendants, 1 with a Class I recall14 generations forward: 16 descendants5 generations forward: 11 descendants, 1 with a Class I recall16 generations forward: 7 descendants, 1 with a Class I recall17 generations forward: 4 descendants K962295 · Precision Qid Blood Glucose Test Strip · Medisense, Inc. · 1996K945887 · Precision Q I D Blood Glucose Test Strips · Medisense, Inc. · 19950+5
  1. Root · 2 generations backK945887 Precision Q I D Blood Glucose Test StripsMedisense, Inc. · 1995
  2. 1 generation backK962295 Precision Qid Blood Glucose Test StripMedisense, Inc. · 1996
  3. This deviceK963676 Precision G Blood Glucose Testing SystemMedisense, Inc. · 1997
  4. Descendant · cites it directly · 59 of its ownK971812 Precision Qid Blood Glucose Test Strip, Precision G Blood Glucose…Medisense, Inc. · 1997
  5. Descendant · cites it directly · 40 of its ownK983504 Precision Xtra Advanced Diabetes Management System, Precision Blood…Medisense, Inc. · 1999 · Recalled
  6. Descendant · 2 generations on · 19 of its ownK052980 Liberty Glucose Control, Model 2120031Liberty Healthcare Group, Inc. · 2005
  7. Descendant · 2 generations on · 16 of its ownK040814 Modification to Precision Xtra Advanced Diabetes Management SystemAbbott Laboratories · 2004 · Recalled
  8. Descendant · cites it directly · 14 of its ownK982303 Precision PCX Point of Care Management System , QC Manager Data…Medisense, Inc. · 1998

Showing 5 of 60 descendants. See all descendants

Descendants cleared per year

1997: 11998: 11999: 12002: 32004: 22005: 42006: 62007: 52008: 72009: 42010: 52011: 12012: 22013: 62015: 22016: 32018: 32020: 12021: 12022: 2
1997high 7 (2008) · low 0 (2000)2026

Class I recalls in this family

Most influential descendants

Showing 5 of 60 · See all
  • K971812Precision Qid Blood Glucose Test Strip, Precision G Blood Glucose Test StripMedisense, Inc. · 1997 · cites it directly59descendants
  • K983504Precision Xtra Advanced Diabetes Management System, Precision Blood Glucose Test Strips…Medisense, Inc. · 1999 · cites it directly40descendants
  • K052980Liberty Glucose Control, Model 2120031Liberty Healthcare Group, Inc. · 2005 · 2 generations on19descendants
  • K040814Modification to Precision Xtra Advanced Diabetes Management SystemAbbott Laboratories · 2004 · 2 generations on16descendants
  • K982303Precision PCX Point of Care Management System , QC Manager Data Manager System…Medisense, Inc. · 1998 · cites it directly14descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−2K945887Precision Q I D Blood Glucose Test StripsMedisense, Inc.1995—
−1K962295Precision Qid Blood Glucose Test StripMedisense, Inc.1996—
0 (this device)K963676Precision G Blood Glucose Testing SystemMedisense, Inc.1997—
+1K971812Precision Qid Blood Glucose Test Strip, Precision G Blood Glucose Test StripMedisense, Inc.1997—
+1K983504Precision Xtra Advanced Diabetes Management System, Precision Blood Glucose…Medisense, Inc.19991
+2K052980Liberty Glucose Control, Model 2120031Liberty Healthcare Group, Inc.2005—
+2K040814Modification to Precision Xtra Advanced Diabetes Management SystemAbbott Laboratories20043
+1K982303Precision PCX Point of Care Management System , QC Manager Data Manager…Medisense, Inc.1998—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199010
199520

Descendants by year cleared

Year clearedDevicesWith a Class I recall
199710
199810
199910
200230
200420
200540
200660
200750
200870
200940
201053
201110
201220
201360
201520
201630
201830
202010
202110
202220
FIG. 1 — Lineage of K963676, 1995–2022Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

3 devices in this family have a Class I recall. A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new CGA device

  1. #1 K252488 ABL90 FLEX PLUS Systemscore 12.8 · 6 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (4)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K944195Quickpro Blood Glucose Testing System
Summary page 1
…Precision G Blood Glucose Testing System Blood Glucose Testing System “Glucose Test System” - Class II per CFR 862.1345 Precision QID Blood Glucose Testing System - K944195 Precision QID Blood Glucose Test Strip - K945887, K962295 Satellite G Blood Glucose Testing System - K896951 The Precision G Blo…
Medisense, Inc.1995—
*K945887Precision Q I D Blood Glucose Test Strips
Summary page 1
…Glucose Testing System “Glucose Test System” - Class II per CFR 862.1345 Precision QID Blood Glucose Testing System - K944195 Precision QID Blood Glucose Test Strip - K945887, K962295 Satellite G Blood Glucose Testing System - K896951 The Precision G Blood Glucose Testing System utilizes amperometric b…
Medisense, Inc.1995—
*K962295Precision Qid Blood Glucose Test Strip
Summary page 1
…Testing System “Glucose Test System” - Class II per CFR 862.1345 Precision QID Blood Glucose Testing System - K944195 Precision QID Blood Glucose Test Strip - K945887, K962295 Satellite G Blood Glucose Testing System - K896951 The Precision G Blood Glucose Testing System utilizes amperometric biosensor…
Medisense, Inc.1996—
*K896951Satellite G Blood Glucose Monitoring System
Summary page 1
…r CFR 862.1345 Precision QID Blood Glucose Testing System - K944195 Precision QID Blood Glucose Test Strip - K945887, K962295 Satellite G Blood Glucose Testing System - K896951 The Precision G Blood Glucose Testing System utilizes amperometric biosensor technology to quantitatively measure glucose in who…
Medisense, Inc.1990—

Also cleared against K944195: 2 other devices →

What descends from it? (60)

See all 60

3 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K971812Precision Qid Blood Glucose Test Strip, Precision G Blood Glucose Test StripMedisense, Inc.199759
K983504Precision Xtra Advanced Diabetes Management System, Precision Blood Glucose Test Strips…Medisense, Inc.199940
K982303Precision PCX Point of Care Management System , QC Manager Data Manager System…Medisense, Inc.199814

Has anything in its family been recalled? (3 Class I)

No FDA recall names this device.

Relatives with a Class I recall

Class I is FDA’s most serious recall class. A recall in the family tree is context for this device, not evidence about it.

  • K091547Nova Max Plus Blood Glucose and B-Ketone Monitor System, Nova Max Plus B-Ketone Control Solutions, Nova Max…Nova Biomedical Corp. · 2010 · 3 generations on · ◆ in the 2010 descendants bar of FIG. 110 Class I recalls
  • K092638Freestyle Blood Glucose Test Strips, Models 100-Count: 12401-01, 12101-21, 12101-22, 12101-23Abbott Diabetes Care, Inc. · 2010 · 5 generations on · ◆ in the 2010 descendants bar of FIG. 12 Class I recalls
  • K092602FREESTYLE Lite Blood Glucose Monitoring System and Freestyle Freedom Lite Blood Glucose Monitoring SystemAbbott Diabetes Care, Inc. · 2010 · 6 generations on · ◆ in the 2010 descendants bar of FIG. 12 Class I recalls

What does this lineage say?

  • The line of descent spans 2 years and passes through 1 company; a new generation was cleared every 1.3 years on median.
  • None of the 5 ancestors has a recall.
  • Of its descendants, K971812 (Medisense, Inc., 1997) has gone furthest, with 59 descendants of its own.
  • 2 other devices also cite its predicate K944195.

How does its category compare?

All CGA devices

CGA Glucose Oxidase, Glucose: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · CGA

2in 2024

2007: 72008: 62009: 102010: 82011: 92012: 102013: 32014: 52015: 42016: 42017: 22018: 22019: 22020: 22021: 12022: 12023: 42024: 22026 (partial year): 1
2007high 10 (2009) · low 0 (2025)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · CGA

249in 2023

2007: 122 days median2008: 56 days median2009: 155 days median2010: 122 days median2011: 217 days median2012: 123 days median2013: 441 days median2014: 265 days median2015: 150 days median2016: 157 days median2023: 249 days median
2007high 441 (2013) · low 56 (2008)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · CGA

3in 2023

2007: 22008: 22009: 42010: 62011: 32013: 32014: 22015: 6, 2 Class I2016: 22019: 12023: 3
2007high 6 (2010) · low 0 (2012)2026

Class I (2 since 2007) Class II/III not classified

Adverse event reports per year · CGA

59in 2025

2007: 292008: 372009: 752010: 1722011: 4232012: 2332013: 1722014: 1222015: 1552016: 362017: 922018: 692019: 1162020: 682021: 482022: 2722023: 1,1412024: 2662025: 59
2007high 1,141 (2023) · low 29 (2007)2025

MAUDE reports naming product code CGA, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20077122229
2008656237
200910155475
201081226172
201192173423
2012101230233
201334413172
201452652122
201541506 (2)155
20164157236
20172—092
20182—069
20192—1116
20202—068
20211—048
20221—0272
2023424931,141
20242—0266
20250—059
20261—0—

What is it indicated for?

The Precision G Blood Glucose Testing System is intended for in vitro diagnostic use (i.e., for external use only) for the quantitative measurement of glucose in fresh whole blood. The Precision G Blood Glucose Testing System is intended for home or professional use. The product may also be used by healthcare professionals for quantitative measurement of glucose in venous or arterial whole blood, provided the sample is used within 15 minutes.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K963676: Precision G Blood Glucose Testing System.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K963676

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026